Eighty percent of U.S. maternal deaths are preventable: Study
“It’s significant. It’s staggering. It’s heartbreaking.”
FDA approves ‘rapid-acting’ oral drug for major depression
It is the "first and only rapid-acting oral medicine approved for the treatment of MDD.
FDA panel rejects pimavanserin for Alzheimer’s psychosis
The FDA will make its final decision by August 4.
FDA requires disclosure of suicide risk for anti-baldness drug
The agency has previously approved revised Propecia labels that mentioned risks of persistent sexual dysfunction and depression but not suicide....
FDA panel strongly backs protein-based Novavax COVID-19 vaccine
“Having a protein-based alternative may be more comfortable for some in terms of their acceptance of vaccines.”
FDA denies petition to disqualify researchers over controversial ketamine studies
“The FDA denied our petition, and we think that sends the wrong signal to the research community.”
Many Americans missing an opportunity to prevent dementia
“Health care professionals should also screen patients for modifiable risk factors, counsel patients with risk factors, and refer them to...
FDA clears diagnostic test for early Alzheimer’s
“There is a new option that can typically be completed the same day and can give doctors the same information regarding brain amyloid status,...
FDA okays first sublingual med for agitation in serious mental illness
With a demonstrated onset of action as early as 20 minutes, dexmedetomidine shows a high response rate in patients at both 120-mcg and 180-mcg...
FDA clears once-weekly transdermal patch for Alzheimer’s
Adlarity is the first and only once-weekly patch to continuously deliver consistent doses of the acetylcholinesterase inhibitor through the skin...
News from the FDA/CDC
Clozapine interrupted: APA, others seek FDA forum on REMS
Clozapine can decrease the neutrophil count, which can lead to severe neutropenia, serious infection, and death.